These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22056593)

  • 21. Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.
    Van de Werf F
    Circulation; 2010 Jan; 121(1):5-7. PubMed ID: 20026787
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation of inhibition of platelet aggregation with cardiovascular and bleeding outcomes in acute coronary syndromes.
    Wada R; Rohatagi S; Small D; Winters KJ; Salazar DE
    J Clin Pharmacol; 2010 Aug; 50(8):904-13. PubMed ID: 20147617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for major bleeding and for minor bleeding after percutaneous coronary intervention in 634 consecutive patients with acute coronary syndromes.
    Pierre-Louis B; Aronow WS; Yoon JH; Ahn C; Kalapatapu K; Pucillo AL; Monsen CE
    Am J Ther; 2010; 17(4):e74-7. PubMed ID: 19455020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet agents in acute coronary syndromes.
    Sakhuja R; Yeh RW; Bhatt DL
    Curr Probl Cardiol; 2010 Mar; 35(3):123-70. PubMed ID: 20152547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Between a rock and a hard place: weighing thrombotic risk against bleeding complications.
    Hudzik B; Polonski L
    Am J Cardiol; 2013 May; 111(9):1375. PubMed ID: 23622104
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute coronary syndromes: a Canadian perspective.
    Fitchett DH
    Can J Cardiol; 2011; 27 Suppl A():S385-6. PubMed ID: 22118041
    [No Abstract]   [Full Text] [Related]  

  • 27. Tug of war.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):1C-3C. PubMed ID: 19695353
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
    Caixeta A; Dangas GD; Mehran R; Feit F; Nikolsky E; Lansky AJ; Aoki J; Moses JW; Steinhubl SR; White HD; Ohman EM; Manoukian SV; Fahy M; Stone GW
    Am Heart J; 2011 Feb; 161(2):298-306.e1. PubMed ID: 21315212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bleeding risk and acute coronary syndromes in the elderly].
    Bounhoure JP; Montastruc JL
    Bull Acad Natl Med; 2011 Nov; 195(8):1981-7. PubMed ID: 22844755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Underuse of antithrombotic and antiplatelet treatments for acute coronary syndrome in China: a note of caution.
    Cheng TO
    Chin Med J (Engl); 2009 May; 122(9):1120. PubMed ID: 19493455
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment.
    Boden H; van der Hoeven BL; Karalis I; Schalij MJ; Jukema JW
    J Intern Med; 2012 Jun; 271(6):521-36. PubMed ID: 22340431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial.
    Husted S; James S; Becker RC; Horrow J; Katus H; Storey RF; Cannon CP; Heras M; Lopes RD; Morais J; Mahaffey KW; Bach RG; Wojdyla D; Wallentin L;
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):680-8. PubMed ID: 22991347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial.
    Husted S; Harrington RA; Cannon CP; Storey RF; Mitchell P; Emanuelsson H
    Int J Clin Pract; 2009 Apr; 63(4):667-70. PubMed ID: 19335707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of hemostasis defects and management of bleeding in patients with acute coronary syndromes.
    Mannucci PM; Franchini M
    Eur J Intern Med; 2010 Aug; 21(4):254-9. PubMed ID: 20603031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic treatment in acute coronary syndromes.
    Hoole SP; Saw J
    Minerva Med; 2010 Aug; 101(4):215-38. PubMed ID: 21030935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation.
    Kuzniatsova N; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1643-7. PubMed ID: 21108546
    [No Abstract]   [Full Text] [Related]  

  • 38. Avoiding and managing bleeding complications in patients with non-ST-segment elevation acute coronary syndromes.
    Potsis TZ; Katsouras C; Goudevenos JA
    Angiology; 2009; 60(2):148-58. PubMed ID: 18508853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Fernandez JS; Sadaniantz A
    Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
    [No Abstract]   [Full Text] [Related]  

  • 40. Preventable deaths, never events, and comparative effectiveness: it is time for US cardiologist to switch to transradial.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):416-7. PubMed ID: 19681112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.